Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dehydroepiandrosterone. Renaissance after 13 years].

J Sonka

    Casopis Lekaru Ceskych
    |September 8, 1989
    PubMed
    Summary

    Dehydroepiandrosterone (DHEA) influences key metabolic enzymes and its deficiency is linked to diseases like obesity and diabetes. DHEA administration shows promise in improving these metabolic disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Metabolic and hormonal links in obese individuals with and without symptoms of syndrome X].

    Sbornik lekarsky·2000
    Same author

    [Case reports of morbid obesity].

    Sbornik lekarsky·2000
    Same author

    [Importance of monitoring insulinemia in obesity].

    Sbornik lekarsky·1999
    Same author

    Long-term results of aggressive weight reduction treatment.

    Sbornik lekarsky·1999
    Same author

    Dexfenfluramine in psychotic patients.

    The International journal of eating disorders·1998
    Same author

    [Insulin, steroids and steroidogenesis].

    Ceskoslovenska fysiologie·1997

    Area of Science:

    • Biochemistry
    • Endocrinology
    • Metabolic pathways

    Context:

    • Dehydroepiandrosterone (DHEA) is a steroid precursor to androgens and estrogens.
    • DHEA inhibits critical enzymes including 11 beta-hydroxylase, NADH oxidase, and glucose 6-phosphate dehydrogenase.
    • Glucose 6-phosphate dehydrogenase is the rate-limiting enzyme of the pentose phosphate pathway.

    Purpose:

    • To investigate the role of DHEA in metabolic regulation.
    • To explore the link between DHEA deficiency and various diseases.
    • To evaluate the therapeutic potential of DHEA administration in metabolic disorders.

    Summary:

    • DHEA deficiency is associated with obesity, type 2 diabetes, hypertension, arteriosclerosis, hyperuricemia, and malignant growth (low DHEA syndrome).
    • DHEA administration demonstrated a favorable impact on several of these metabolic disorders.
    • The pentose phosphate pathway, crucial for NADPH and pentose phosphate production, is influenced by DHEA.

    Impact:

    • Highlights the significant role of DHEA in maintaining metabolic health.
    • Suggests DHEA as a potential therapeutic agent for metabolic diseases.
    • Underscores the need for further research into DHEA's biochemical functions and clinical applications.

    Related Experiment Videos